---
title: "CAR T-cell Therapy for CNS Malignancies: Review Scope and Evidence Gaps"
id: "frontiers-in-immunology-15-car-t-cells-for-the-treatment-of-cns-malignancies"
canonical_url: "https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-car-t-cells-for-the-treatment-of-cns-malignancies"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "Frontiers in Immunology"
source_url: "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1891659"
published_at: "2026-09-03T00:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# CAR T-cell Therapy for CNS Malignancies: Review Scope and Evidence Gaps
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-car-t-cells-for-the-treatment-of-cns-malignancies
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** Frontiers in Immunology
- **Source URL:** [Original Journal Publication](https://www.frontiersin.org/articles/10.3389/fimmu.2026.1891659)
- **Published At:** 2026-09-03T00:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The source document linked (Frontiers in Immunology article titled “CAR T-cells for the treatment of CNS malignancies”) contained only website navigation and header material; the article body, data, and conclusions were not present in the provided source. - Because the provided source did not include the manuscript text, no primary study results, trial data, safety outcomes, or specific clinical recommendations were available to extract. - Key topic terms apparent from the title are **CAR T-cells** and **CNS malignancies**, but the source did not report definitions, target antigens, clinical indications, or mechanisms relevant to those terms. - The absence of article content means details commonly expected in such a review—preclinical evidence, clinical trial summaries, delivery strategies across the blood–brain barrier, neurotoxicity reports, and combination therapy approaches—were not reported in the source. - The rewritten article below provides a structured editorial summary framework and highlights expected thematic areas for clinicians and researchers, while explicitly noting where the source lacked content and where specifics could not be reported. - Any specific data points, trial names, numerical outcomes, dates, author statements, and recommendations are not included because they were not present in the supplied source. - Readers should consult the full published article at the journal site for complete and authoritative details; this summary is limited to the information available in the provided source file.
## Clinical Analysis & Structured Key Points
[](https://www.frontiersin.org/) [ ![](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1891659/full) Frontiers in Immunology ](https://www.frontiersin.org/journals/immunology) About us About us * Who we are * [Mission and values](https://www.frontiersin.org/about/mission) * [History](https://www.frontiersin.org/about/history) * [Leadership](https://www.frontiersin.org/about/leadership) * [Awards](https://www.frontiersin.org/about/awards) * Impact and progress * [Frontiers' impact](https://www.frontiersin.org/about/impact) * [Our annual reports](https://www.frontiersin.org/about/annual-reports) * [Thought leadership](https://www.frontiersin.org/about/thought-leadership) * [Researcher perspectives](https://www.frontiersin.org/about/researcher-perspectives) * Publishing model * [How we publish](https://www.frontiersin.org/about/how-we-publish) * [Open access](https://www.frontiersin.org/about/open-access) * [Quality and research integrity](https://www.frontiersin.org/about/quality) * [Peer review](https://www.frontiersin.org/about/peer-review) * [Technology and platforms](https://www.frontiersin.org/about/technology-and-platforms) * [Research Topics](https://www.frontiersin.org/about/research-topics) * [Publish your data with FAIR²](https://www.frontiersin.org/about/fair-data-management) * [Fee policy](https://www.frontiersin.org/about/fee-policy) * Services * [Societies](https://publishingpartnerships.frontiersin.org/) * [National consortia](https://www.frontiersin.org/open-access-agreements/consortia) * [Institutional partnerships](https://www.frontiersin.org/about/open-access-agreements) * [Collaboration and indexation](https://www.frontiersin.org/about/collaboration-indexation) * More from Frontiers * [Frontiers Forum](https://forum.frontiersin.org/) * [Frontiers Planet Prize](https://www.frontiersin.org/about/frontiers-planet-prize) * [Press office](https://pressoffice.frontiersin.org/) * [Sustainability](https://www.frontiersin.org/about/sustainability) * [Career opportunities](https://careers.frontiersin.org/) * [Contact us](https://www.frontiersin.org/about/contact) [All journals](https://www.frontiersin.org/journals)[All articles](https://www.frontiersin.org/articles) [Submit manuscript](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entitytype=2&entityid=276)[Submit data](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entitytype=2&entityid=276&articletypeid=246) [Search](https://www.frontiersin.org/search?tab=top-results&origin=https%3A%2F%2Fwww.frontiersin.org%2Fjournals%2Fimmunology%2Farticles%2F10.3389%2Ffimmu.2026.1891659%2Ffull)[Login](https://www.frontiersin.org/people/login?returnUrl=https%3A%2F%2Fwww.frontiersin.org%2Fjournals%2Fimmunology%2Farticles%2F10.3389%2Ffimmu.2026.1891659%2Ffull) [](https://www.frontiersin.org/) [ ![](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1891659/full) Frontiers in Immunology ](https://www.frontiersin.org/journals/immunology) Sections Sections * [Alloimmunity and Transplantation](https://www.frontiersin.org/journals/immunology/sections/alloimmunity-and-transplantation) * [Autoimmune Disorders](https://www.frontiersin.org/journals/immunology/sections/autoimmune-disorders) * [Autoinflammatory Disorders](https://www.frontiersin.org/journals/immunology/sections/autoinflammatory-disorders) * [B Cell Biology](https://www.frontiersin.org/journals/immunology/sections/b-cell-biology) * [Cancer Immunity and Immunotherapy](https://www.frontiersin.org/journals/immunology/sections/cancer-immunity-and-immunotherapy) * [Comparative Immunology](https://www.frontiersin.org/journals/immunology/sections/comparative-immunology) * [Cytokines and Soluble Mediators in Immunity](https://www.frontiersin.org/journals/immunology/sections/cytokines-and-soluble-mediators-in-immunity) * [Dendritic Cells, Macrophages and APC Immunology](https://www.frontiersin.org/journals/immunology/sections/dendritic-cells-macrophages-and-apc-immunology) * [Immunological Memory](https://www.frontiersin.org/journals/immunology/sections/immunological-memory) * [Immunological Tolerance and Regulation](https://www.frontiersin.org/journals/immunology/sections/immunological-tolerance-and-regulation) * [Inflammation](https://www.frontiersin.org/journals/immunology/sections/inflammation) * [Methods and New Technologies in Immunology](https://www.frontiersin.org/journals/immunology/sections/methods-and-new-technologies-in-immunology) * [Microbial Immunology](https://www.frontiersin.org/journals/immunology/sections/microbial-immunology) * [Molecular Innate Immunity](https://www.frontiersin.org/journals/immunology/sections/molecular-innate-immunity) * [Mucosal Immunity](https://www.frontiersin.org/journals/immunology/sections/mucosal-immunity) * [Multiple Sclerosis and Neuroimmunology](https://www.frontiersin.org/journals/immunology/sections/multiple-sclerosis-and-neuroimmunology) * [NK and Innate Lymphoid Cell Biology](https://www.frontiersin.org/journals/immunology/sections/nk-and-innate-lymphoid-cell-biology) * [Nutritional Immunology](https://www.frontiersin.org/journals/immunology/sections/nutritional-immunology) * [Parasite Immunology](https://www.frontiersin.org/journals/immunology/sections/parasite-immunology) * [Primary Immunodeficiencies](https://www.frontiersin.org/journals/immunology/sections/primary-immunodeficiencies) * [Sex Differences in Immunology](https://www.frontiersin.org/journals/immunology/sections/sex-differences-in-immunology) * [Systems Immunology](https://www.frontiersin.org/journals/immunology/sections/systems-immunology) * [T Cell Biology](https://www.frontiersin.org/journals/immunology/sections/t-cell-biology) * [Vaccines and Molecular Therapeutics](https://www.frontiersin.org/journals/immunology/sections/vaccines-and-molecular-therapeutics) * [Viral Immunology](https://www.frontiersin.org/journals/immunology/sections/viral-immunology) [Articles](https://www.frontiersin.org/journals/immunology/articles)[Research Topics](https://www.frontiersin.org/journals/immunology/research-topics)[Editorial board](https://www.frontiersin.org/journals/immunology/editors) About journal About journal * Scope * [Field chief editors](https://www.frontiersin.org/journals/immunology/about#about-editors) * [Mission and scope](https://www.frontiersin.org/journals/immunology/about#about-scope) * [Facts](https://www.frontiersin.org/journals/immunology/about#about-facts) * [Journal sections](https://www.frontiersin.org/journals/immunology/about#about-submission) * [Open access statement](https://www.frontiersin.org/journals/immunology/about#about-open) * [Copyright statement](https://www.frontiersin.org/journals/immunology/about#copyright-statement) * [Quality](https://www.frontiersin.org/journals/immunology/about#about-quality) * For authors * [Why submit?](https://www.frontiersin.org/journals/immunology/for-authors/why-submit) * [Article types](https://www.frontiersin.org/journals/immunology/for-authors/article-types) * [Author guidelines](https://www.frontiersin.org/journals/immunology/for-authors/author-guidelines) * [Editor guidelines](https://www.frontiersin.org/journals/immunology/for-authors/editor-guidelines) * [Publishing fees](https://www.frontiersin.org/journals/immunology/for-authors/publishing-fees) * [Submission checklist](https://www.frontiersin.org/journals/immunology/for-authors/submission-checklist) * [Contact editorial office](https://www.frontiersin.org/journals/immunology/for-authors/contact-editorial-office) About us About us * Who we are * [Mission and values](https://www.frontiersin.org/about/mission) * [History](https://www.frontiersin.org/about/history) * [Leadership](https://www.frontiersin.org/about/leadership) * [Awards](https://www.frontiersin.org/about/awards) * Impact and progress * [Frontiers' impact](https://www.frontiersin.org/about/impact) * [Our annual reports](https://www.frontiersin.org/about/annual-reports) * [Thought leadership](https://www.frontiersin.org/about/thought-leadership) * [Researcher perspectives](https://www.frontiersin.org/about/researcher-perspectives) * Publishing model * [How we publish](https://www.frontiersin.org/about/how-we-publish) * [Open access](https://www.frontiersin.org/about/open-access) * [Quality and research integrity](https://www.frontiersin.org/about/quality) * [Peer review](https://www.frontiersin.org/about/peer-review) * [Technology and platforms](https://www.frontiersin.org/about/technology-and-platforms) * [Research Topics](https://www.frontiersin.org/about/research-topics) * [Publish your data with FAIR²](https://www.frontiersin.org/about/fair-data-management) * [Fee policy](https://www.frontiersin.org/about/fee-policy) * Services * [Societies](https://publishingpartnerships.frontiersin.org/) * [National consortia](https://www.frontiersin.org/open-access-agreements/consortia) * [Institutional partnerships](https://www.frontiersin.org/about/open-access-agreements) * [Collaboration and indexation](https://www.frontiersin.org/about/collaboration-indexation) * More from Frontiers * [Frontiers Forum](https://forum.frontiersin.org/) * [Frontiers Planet Prize](https://www.frontiersin.org/about/frontiers-planet-prize) * [Press office](https://pressoffice.frontiersin.org/) * [Sustainability](https://www.frontiersin.org/about/sustainability) * [Career opportunities](https://careers.frontiersin.org/) * [Contact us](https://www.frontiersin.org/about/contact) [All journals](https://www.frontiersin.org/journals)[All articles](https://www.frontiersin.org/articles) [Submit manuscript](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entitytype=2&entityid=276)[Submit data](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entitytype=2&entityid=276&articletypeid=246) [ ![](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1891659/full) Frontiers in Immunology ](https://www.frontiersin.org/journals/immunology) Sections Sections * [Alloimmunity and Transplantation](https://www.frontiersin.org/journals/immunology/sections/alloimmunity-and-transplantation) * [Autoimmune Disorders](https://www.frontiersin.org/journals/immunology/sections/autoimmune-disorders) * [Autoinflammatory Disorders](https://www.frontiersin.org/journals/immunology/sections/autoinflammatory-disorders) * [B Cell Biology](https://www.frontiersin.org/journals/immunology/sections/b-cell-biology) * [Cancer Immunity and Immunotherapy](https://www.frontiersin.org/journals/immunology/sections/cancer-immunity-and-immunotherapy) * [Comparative Immunology](https://www.frontiersin.org/journals/immunology/sections/comparative-immunology) * [Cytokines and Soluble Mediators in Immunity](https://www.frontiersin.org/journals/immunology/sections/cytokines-and-soluble-mediators-in-immunity) * [Dendritic Cells, Macrophages and APC Immunology](https://www.frontiersin.org/journals/immunology/sections/dendritic-cells-macrophages-and-apc-immunology) * [Immunological Memory](https://www.frontiersin.org/journals/immunology/sections/immunological-memory) * [Immunological Tolerance and Regulation](https://www.frontiersin.org/journals/immunology/sections/immunological-tolerance-and-regulation) * [Inflammation](https://www.frontiersin.org/journals/immunology/sections/inflammation) * [Methods and New Technologies in Immunology](https://www.frontiersin.org/journals/immunology/sections/methods-and-new-technologies-in-immunology) * [Microbial Immunology](https://www.frontiersin.org/journals/immunology/sections/microbial-immunology) * [Molecular Innate Immunity](https://www.frontiersin.org/journals/immunology/sections/molecular-innate-immunity) * [Mucosal Immunity](https://www.frontiersin.org/journals/immunology/sections/mucosal-immunity) * [Multiple Sclerosis and Neuroimmunology](https://www.frontiersin.org/journals/immunology/sections/multiple-sclerosis-and-neuroimmunology) * [NK and Innate Lymphoid Cell Biology](https://www.frontiersin.org/journals/immunology/sections/nk-and-innate-lymphoid-cell-biology) * [Nutritional Immunology](https://www.frontiersin.org/journals/immunology/sections/nutritional-immunology) * [Parasite Immunology](https://www.frontiersin.org/journals/immunology/sections/parasite-immunology) * [Primary Immunodeficiencies](https://www.frontiersin.org/journals/immunology/sections/primary-immunodeficiencies) * [Sex Differences in Immunology](https://www.frontiersin.org/journals/immunology/sections/sex-differences-in-immunology) * [Systems Immunology](https://www.frontiersin.org/journals/immunology/sections/systems-immunology) * [T Cell Biology](https://www.frontiersin.org/journals/immunology/sections/t-cell-biology) * [Vaccines and Molecular Therapeutics](https://www.frontiersin.org/journals/immunology/sections/vaccines-and-molecular-therapeutics) * [Viral Immunology](https://www.frontiersin.org/journals/immunology/sections/viral-immunology) [Articles](https://www.frontiersin.org/journals/immunology/articles)[Research Topics](https://www.frontiersin.org/journals/immunology/research-topics)[Editorial board](https://www.frontiersin.org/journals/immunology/editors) About journal About journal * Scope * [Field chief editors](https://www.frontiersin.org/journals/immunology/about#about-editors) * [Mission and scope](https://www.frontiersin.org/journals/immunology/about#about-scope) * [Facts](https://www.frontiersin.org/journals/immunology/about#about-facts) * [Journal sections](https://www.frontiersin.org/journals/immunology/about#about-submission) * [Open access statement](https://www.frontiersin.org/journals/immunology/about#about-open) * [Copyright statement](https://www.frontiersin.org/journals/immunology/about#copyright-statement) * [Quality](https://www.frontiersin.org/journals/immunology/about#about-quality) * For authors * [Why submit?](https://www.frontiersin.org/journals/immunology/for-authors/why-submit) * [Article types](https://www.frontiersin.org/journals/immunology/for-authors/article-types) * [Author guidelines](https://www.frontiersin.org/journals/immunology/for-authors/author-guidelines) * [Editor guidelines](https://www.frontiersin.org/journals/immunology/for-authors/editor-guidelines) * [Publishing fees](https://www.frontiersin.org/journals/immunology/for-authors/publishing-fees) * [Submission checklist](https://www.frontiersin.org/journals/immunology/for-authors/submission-checklist) * [Contact editorial office](https://www.frontiersin.org/journals/immunology/for-authors/contact-editorial-office) [](https://www.frontiersin.org/) [ ![](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1891659/full) Frontiers in Immunology ](https://www.frontiersin.org/journals/immunology) Sections Sections * [Alloimmunity and Transplantation](https://www.frontiersin.org/journals/immunology/sections/alloimmunity-and-transplantation) * [Autoimmune Disorders](https://www.frontiersin.org/journals/immunology/sections/autoimmune-disorders) * [Autoinflammatory Disorders](https://www.frontiersin.org/journals/immunology/sections/autoinflammatory-disorders) * [B Cell Biology](https://www.frontiersin.org/journals/immunology/sections/b-cell-biology) * [Cancer Immunity and Immunotherapy](https://www.frontiersin.org/journals/immunology/sections/cancer-immunity-and-immunotherapy) * [Comparative Immunology](https://www.frontiersin.org/journals/immunology/sections/comparative-immunology) * [Cytokines and Soluble Mediators in Immunity](https://www.frontiersin.org/journals/immunology/sections/cytokines-and-soluble-mediators-in-immunity) * [Dendritic Cells, Macrophages and APC Immunology](https://www.frontiersin.org/journals/immunology/sections/dendritic-cells-macrophages-and-apc-immunology) * [Immunological Memory](https://www.frontiersin.org/journals/immunology/sections/immunological-memory) * [Immunological Tolerance and Regulation](https://www.frontiersin.org/journals/immunology/sections/immunological-tolerance-and-regulation) * [Inflammation](https://www.frontiersin.org/journals/immunology/sections/inflammation) * [Methods and New Technologies in Immunology](https://www.frontiersin.org/journals/immunology/sections/methods-and-new-technologies-in-immunology) * [Microbial Immunology](https://www.frontiersin.org/journals/immunology/sections/microbial-immunology) * [Molecular Innate Immunity](https://www.frontiersin.org/journals/immunology/sections/molecular-innate-immunity) * [Mucosal Immunity](https://www.frontiersin.org/journals/immunology/sections/mucosal-immunity) * [Multiple Sclerosis and Neuroimmunology](https://www.frontiersin.org/journals/immunology/sections/multiple-sclerosis-and-neuroimmunology) * [NK and Innate Lymphoid Cell Biology](https://www.frontiersin.org/journals/immunology/sections/nk-and-innate-lymphoid-cell-biology) * [Nutritional Immunology](https://www.frontiersin.org/journals/immunology/sections/nutritional-immunology) * [Parasite Immunology](https://www.frontiersin.org/journals/immunology/sections/parasite-immunology) * [Primary Immunodeficiencies](https://www.frontiersin.org/journals/immunology/sections/primary-immunodeficiencies) * [Sex Differences in Immunology](https://www.frontiersin.org/journals/immunology/sections/sex-differences-in-immunology) * [Systems Immunology](https://www.frontiersin.org/journals/immunology/sections/systems-immunology) * [T Cell Biology](https://www.frontiersin.org/journals/immunology/sections/t-cell-biology) * [Vaccines and Molecular Therapeutics](https://www.frontiersin.org/journals/immunology/sections/vaccines-and-molecular-therapeutics) * [Viral Immunology](https://www.frontiersin.org/journals/immunology/sections/viral-immunology) [Articles](https://www.frontiersin.org/journals/immunology/articles)[Research Topics](https://www.frontiersin.org/journals/immunology/research-topics)[Editorial board](https://www.frontiersin.org/journals/immunology/editors) About journal About journal * Scope * [Field chief editors](https://www.frontiersin.org/journals/immunology/about#about-editors) * [Mission and scope](https://www.frontiersin.org/journals/immunology/about#about-scope) * [Facts](https://www.frontiersin.org/journals/immunology/about#about-facts) * [Journal sections](https://www.frontiersin.org/journals/immunology/about#about-submission) * [Open access statement](https://www.frontiersin.org/journals/immunology/about#about-open) * [Copyright statement](https://www.frontiersin.org/journals/immunology/about#copyright-statement) * [Quality](https://www.frontiersin.org/journals/immunology/about#about-quality) * For authors * [Why submit?](https://www.frontiersin.org/journals/immunology/for-authors/why-submit) * [Article types](https://www.frontiersin.org/journals/immunology/for-authors/article-types) * [Author guidelines](https://www.frontiersin.org/journals/immunology/for-authors/author-guidelines) * [Editor guidelines](https://www.frontiersin.org/journals/immunology/for-authors/editor-guidelines) * [Publishing fees](https://www.frontiersin.org/journals/immunology/for-authors/publishing-fees) * [Submission checklist](https://www.frontiersin.org/journals/immunology/for-authors/submission-checklist) * [Contact editorial office](https://www.frontiersin.org/journals/immunology/for-authors/contact-editorial-office) [Submit manuscript](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entitytype=2&entityid=276)[Submit data](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entity
## Related Clinical Research

- [Fingolimod triggers apoptosis-like death and cytotoxic stress in AML including P-glycoprotein–over](https://medichelpline.com/clinical-feed/pubmed-42269275.md) (DOI: 10.1016/j.bbrc.2026.154118)
- [Personalized mRNA vaccine plus pembrolizumab lowers melanoma recurrence in phase 3 trial](https://medichelpline.com/clinical-feed/medical-news-today-0-novel-mrna-vaccine-plus-immunotherapy-reduces-melanoma-relapse-in-phase-3-trial.md)
- [Higher dietary antioxidants linked to lower odds of cervical cancer in NHANES analysis](https://medichelpline.com/clinical-feed/medical-news-today-1-study-finds-link-between-antioxidant-rich-diets-and-lower-cervical-cancer-odds.md)
- [Clinical Trial Enrollment: Common Barriers and What Patients Should Know](https://medichelpline.com/clinical-feed/kff-health-news-1-you-want-to-join-a-clinical-trial-here-s-what-to-know-about-the-hurdles.md)
- [Intrathecal Methotrexate for Leptomeningeal Metastases in Urothelial Carcinoma: Case Report](https://medichelpline.com/clinical-feed/pubmed-42607018.md) (DOI: 10.12659/AJCR.951572)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.